5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m<sup>5</sup>C reader.

Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, Sun HY, Zhu Q, Ma HL, Adhikari S, Sun M, Hao YJ, Zhang B, Huang CM, Huang N, Jiang GB, Zhao YL, Wang HL, Sun YP, Yang YG. · 2017

Read 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m<sup>5</sup>C reader. by Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, Sun HY, Zhu Q, Ma HL, Adhikari S, Sun M, Hao YJ, Zhang B, Huang CM, Huang N, Jiang GB, Zhao YL, Wang HL, Sun YP, Yang YG. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5594206.txt.

Introduction

Xin Yang and co-authors map a chemical mark on messenger RNA in Cell Research. The mark is 5-methylcytosine, or m5C. It was long known on transfer and ribosomal RNA. Its job on messenger RNA stayed unclear.

The team charted m5C across human cells and mouse tissues. Marks cluster in CG-rich stretches, just past the start of protein-coding regions. Patterns are shared across mammals, yet shift by tissue and time. An enzyme called NSUN2 writes most of the marks. A shuttle protein, ALYREF, reads them. ALYREF binds marked RNA and helps export it from the nucleus. Removing NSUN2 broke that export. Adding back the working enzyme fixed it. A dead version could not. Readers get a writer-reader pair that governs RNA traffic.

Catalog record

CREATORYang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, Sun HY, Zhu Q, Ma HL, Adhikari S, Sun M, Hao YJ, Zhang B, Huang CM, Huang N, Jiang GB, Zhao YL, Wang HL, Sun YP, Yang YG.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5594206

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader By Xin Yang, Ying Yang, Bao-Fa Sun, Yu-Sheng Chen, Jia-Wei Xu, Wei-Yi Lai, Ang Li, Xing Wang, Devi Prasad Bhattarai, Wen Xiao, Hui-Ying Sun, Qin Zhu Published in: Cell Research DOI: 10.1038/cr.2017.55 ABSTRACT 5-methylcytosine (m5C) is a post-transcriptional RNA modification identified in both stable and highly abundant tRNAs and rRNAs, and in mRNAs. However, its regulatory role in mRNA metabolism is still largely unknown. Here, we reveal that m5C modification is enriched in CG-rich regions and in regions immediately downstream of translation initiation sites and has conserved, tissue-specific and dynamic features across mammalian transcriptomes. Moreover, m5C formation in mRNAs is mainly catalyzed by the RNA methyltransferase NSUN2, and m5C is specifically recognized by the mRNA export adaptor ALYREF as shown by in vitro and in vivo studies. NSUN2 modulates ALYREF's nuclear-cytoplasmic shuttling, RNA-binding affinity and associated mRNA export. Dysregulation of ALYREF-mediated mRNA export upon NSUN2 depletion could be restored by reconstitution of wild-type but not methyltransferase-defective NSUN2. Our study provides comprehensive m5C profiles of mammalian transcriptomes and suggests an essential role for m5C modification in mRNA export and post-transcriptional regulation. INTRODUCTION The identification of fat mass and obesity-associated (FTO) as the first discovered RNA m6A demethylase1 established the reversible nature of m6A modification. Since then, accumulating lines of evidence have pointed to a broad effect of m6A on mRNA metabolism2,3,4,5,6,7,8,9,10,11,12,13,14. More recently, another two RNA modifications, pseudouridine (ψ)15,16,17 and N1-methyladenosine (m1A)18,19, have also been shown to play a vital role in posttranscriptional gene regulation. All these lines of emerging evidence point to the logical speculation that reversible RNA modifications may serve as novel epigenetic markers with profound biological significance in RNA metabolism. Another important RNA modification, 5-methylcytosine (m5C), was first identified in stable and highly abundant tRNAs and rRNAs20,21,22. Subsequently, many known or novel m5C sites have been validated by using advanced high-throughput techniques combined with next-generation sequencing (NGS). These include RNA bisulfite sequencing (RNA-BisSeq)22,23, m5C-RNA immunoprecipitation (RIP)24, 5-azacytidine-mediated RNA immunoprecipitation (Aza-IP)25 and methylation-individual-nucleotide-resolution crosslinking and immunoprecipitation (miCLIP)26. Based on available published data, a clear view of m5C modification in non-coding RNAs (ncRNAs) has been established, and many m5C sites have also been identified in mRNAs23,25,26,27,28. However, the knowledge about the prevalence and transcriptome-wide distribution of m5C in different species and tissues is still very limited. One recent study observed that m5C sites preferentially occur in the vicinity of the translational start codon in mouse embryonic stem (ES) cells and brain27. However, this feature was not detected in Arabidopsis28. Therefore, it is crucial to clarify how m5C modifications are distributed on mRNAs in different cell types, tissues, and organisms, and to identify and characterize the roles of the protein factors responsible for adding/removing/reading these modifications in order to gain better understanding of the potential significance of m5C modification for RNA metabolism. In this study, we mapped transcriptome-wide m5C profiles in human HeLa cells and multiple mouse tissues using RNA-BisSeq. The distributive analysis showed that m5C sites were mainly enriched in the CG context and also in regions immediately downstream of translation initiation sites of mRNAs, and displayed conserved, tissue-specific and dynamic features in mammalian transcriptomes. We further identified that NSUN2 is the main enzyme catalyzing m5C formation, while Aly/REF export factor (ALYREF, an mRNA transport adaptor, also named THOC4) functions as a specific mRNA m5C-binding protein regulating mRNA export. Our data provide a comprehensive description of m5C methylomes in mammalian transcriptomes and further illustrate an essential role of m5C in regulating mRNA export. RESULTS Distribution profiles of m5C in mRNAs To obtain a transcriptome-wide landscape of m5C profiles, we performed RNA-BisSeq analysis on RNA samples purified from human HeLa cells. Based on a recently described method29, we used ACT random hexamers devoid of Gs to prime the reverse transcription (RT) of bisulfite-treated poly(A)-enriched RNA samples aiming to avoid copying inefficiently deaminated RNA templates. Since RNA-BisSeq cannot distinguish m5C from its potential oxidation product of hm5C, we applied UHPLC-MRM-MS/MS (ultra-high-performance liquid chromatography-triple quadrupole mass spectrometry coupled with multiple-reaction monitoring) to verify the presence of m5C and hm5C in mammalian mRNAs. Unlike the readily detectable m5C, we observed hm5C levels to be very low in human and mouse mRNAs (Supplementary information, Figure S1A), consistent with a recent report30. To ensure efficient conversion of RNA-BisSeq samples, the threshold for global conversion rate (C to T) was set to > 99.6% using dihydrofolate reductase (Dhfr) as the methylation conversion control (Supplementary information, Table S1). Validation of mRNA m5C sites identified by RNA-BisSeq was undertaken by randomly selecting several m5C sites for subsequent PCR amplification and Sanger sequencing. All of the Cs were demonstrated to be converted to Ts except the methylated sites detected by RNA-BisSeq (Figure 1A and Supplementary information, Figure S1B). Thus, by choosing the ACT random hexamers and the most stringent conversion conditions, the RNA-BisSeq approach was capable of faithfully identifying m5C sites in transcriptomes. The data from RNA-BisSeq were shown to be highly reproducible between independent replicates (Supplementary information, Figure S1C, S1D, Tables S1 and S2). A total of 5 399 m5C sites within 2 243 RNA molecules identified in both HeLa replicates (“high-confidence” set) were used in subsequent bioinformatic analyses. Among the m5C sites identified, a majority (94%, 5 063/5 399) were found to occur within 1 995 mRNAs (Supplementary information, Figure S1E). The remaining 336 m5C sites were mapped to diverse types of ncRNAs, predominantly to lncRNAs, including pseudogene transcripts, processed transcripts, lincRNAs, natural antisense transcripts and others (Supplementary information, Figure S1F). Notably, the median methylation level of mRNA m5C sites is about 20.5% (Figure 1B), similar to the degree of mRNA pseudouridylation or editing (Figure 1C), two other types of RNA modifications that have been quantified throughout the transcriptome at single-nucleotide resolution16,31. The distribution profile of m5C sites in mRNA was then examined and the most abundant m5C modification was found to be in coding sequence (CDS, 45%) (Figure 1D). Interestingly, mRNA m5C sites were 55% in CG regions, 28% in CHG regions and 17% in CHH regions (where H = A, C, U) after normalizing m5C numbers in each of three contexts to their individual context proportion within transcriptome (Figure 1E and Supplementary information, Figure S1G). A sequence frequency logo demonstrates that m5C sites, similar to m1A18, are embedded in CG-rich environments (Figure 1F). We next determined the enrichment feature of m5C sites in mRNA transcripts. Intriguingly, in addition to distribution in the vicinity of the binding regions for Argonaute proteins within 3′ UTRs23, we further observed that m5C sites are also enriched in regions immediately downstream of translation initiation sites (Figure 1G). This is similar to a recently published observation in mouse ES cells27 and different from the distribution of m6A that is enriched near stop codons and in 3′ UTRs2,3. A peak of the numbers of m5C sites was observed around 100 nucleotides after translation initiation sites across the whole length of CDS regions (Figure 1H), whereas no obvious “C” enrichment near translation initiation sites along mRNAs was observed (Supplementary information, Figure S1H). Moreover, there is no obvious correlation between m5C levels and mRNA abundance (Supplementary information, Figure S1I), suggesting that m5C probably participates in mRNA posttranscriptional processing. To gain

Read the complete text